---
$id: https://graph.org.ai/products/commodity/51312108
$type: Product
source: UNSPSC
code: "51312108"
title: "Olopatadine hydrochloride"
class: "51312100"
classTitle: "Antihistamine or H1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Olopatadine hydrochloride

**UNSPSC Code**: 51312108
**Class**: [Antihistamine or H1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates](Antihistamine or H1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H23NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2XG66W44KF, chemically known as 11-((z)-3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid but more generally known as olopatadine hydrochloride, which bears US NIH Compound Identifier 5281071. European Medicines Agency schedules Olopatadine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03509MIG. Most nations, for tariff and trade purposes, schedule olopatadine hydrochloride under HS 29329985 and SITC 51569. As of Q4 2014, OLOPATADINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Olopatadine hydrochloride bears US NLM identifiers UMLS ID C0771892 and NCI Concept Code C61867. SMILES: CN(C)CC/C=C\1/C2CCCCC2COC3C1CC(CC3)CC(=O)O.CL.

